CD274 and cancer: According to our gene expression analysis focused on cancer tissues, activation of such targetable pathways is not common but rather individualized, and our findings suggest the need for individualized therapeutic strategies targeting treatments directed at these genes to discern the activated state following treatment with anti-PD-L1-CRT (Supplementary Fig. S5).